Condition
Aldosteronism
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06090617Recruiting
Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn
NCT04890444Recruiting
China Adrenal Disease Registry
NCT05232162UnknownPrimary
Establishment of Aldosterone and Renin Reference Range
NCT01267747Completed
Prevalence of Primary Aldosteronism in Hypertensive Patients Presenting With Atrial Flutter or Fibrillation
NCT00746070UnknownPrimary
Postoperative Cardiovascular Index Change of Primary Aldosteronism
Showing all 5 trials